The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Trending
- Rachel Reeves gives Mais lecture calling for rapid AI adoption and deeper ties with EU – business live | Business
- Nvidia adds Hyundai, BYD, other automakers to AV business
- Crypto Price Prediction Today 16 March – XRP, Pi Coin, PEPE
- Volatility has boosted dividend stocks. These are one firm’s favorites
- High-Value Settlement: Why Stablecoins are Bridging the Gap for Global Payments
- Private Credit Default Rates to Reach 8%, Morgan Stanley Says
- From AI Chips to Shipping: What Micron and FedEx Earnings Mean for the Economy
- Costco recalls meatloaf meal kits in 26 states over Salmonella risk
Tuesday, March 17
